United States · FDA National Drug Code directory

Ciprofloxacin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2450_a5fcba51-4ab6-4b4a-a73d-64dec62a2e52
Product NDC
71335-2450
Form
TABLET
Composition / generic term
Ciprofolxacin
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20231001
Source listing expiry
20261231

Source-listed ingredients

  • CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 7 TABLET in 1 BOTTLE (71335-2450-0) · 71335-2450-0
  • 14 TABLET in 1 BOTTLE (71335-2450-1) · 71335-2450-1
  • 30 TABLET in 1 BOTTLE (71335-2450-2) · 71335-2450-2
  • 20 TABLET in 1 BOTTLE (71335-2450-3) · 71335-2450-3
  • 60 TABLET in 1 BOTTLE (71335-2450-4) · 71335-2450-4
  • 6 TABLET in 1 BOTTLE (71335-2450-5) · 71335-2450-5
  • 10 TABLET in 1 BOTTLE (71335-2450-6) · 71335-2450-6
  • 28 TABLET in 1 BOTTLE (71335-2450-7) · 71335-2450-7
  • 100 TABLET in 1 BOTTLE (71335-2450-8) · 71335-2450-8
  • 40 TABLET in 1 BOTTLE (71335-2450-9) · 71335-2450-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →